Matthias Frick

2.8k total citations
68 papers, 1.8k citations indexed

About

Matthias Frick is a scholar working on Cardiology and Cardiovascular Medicine, Surgery and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Matthias Frick has authored 68 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 43 papers in Cardiology and Cardiovascular Medicine, 16 papers in Surgery and 12 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Matthias Frick's work include Cardiovascular Health and Disease Prevention (13 papers), Cardiac Imaging and Diagnostics (12 papers) and Acute Myocardial Infarction Research (9 papers). Matthias Frick is often cited by papers focused on Cardiovascular Health and Disease Prevention (13 papers), Cardiac Imaging and Diagnostics (12 papers) and Acute Myocardial Infarction Research (9 papers). Matthias Frick collaborates with scholars based in Austria, Poland and United States. Matthias Frick's co-authors include Otmar Pachinger, Hannes Alber, Franz Weidinger, Wolfgang Dichtl, Hanno Ulmer, Józef Dulak, Severin P. Schwarzacher, Gerhard Poelzl, Alois Suessenbacher and Mikko P.S. Ares and has published in prestigious journals such as Journal of the American College of Cardiology, Scientific Reports and CHEST Journal.

In The Last Decade

Matthias Frick

63 papers receiving 1.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Matthias Frick Austria 24 728 495 347 290 231 68 1.8k
Takehiro Matsumoto Japan 17 1.1k 1.5× 278 0.6× 336 1.0× 418 1.4× 176 0.8× 69 1.9k
Yi‐Da Tang China 23 744 1.0× 399 0.8× 545 1.6× 379 1.3× 154 0.7× 132 2.0k
Masayuki Takamura Japan 31 1.3k 1.8× 729 1.5× 552 1.6× 247 0.9× 188 0.8× 220 2.9k
Steven J.R. Meex Netherlands 24 655 0.9× 313 0.6× 271 0.8× 278 1.0× 129 0.6× 69 1.6k
Devaki Nair United Kingdom 23 480 0.7× 708 1.4× 191 0.6× 324 1.1× 326 1.4× 53 1.8k
Yuichi Nakamura Japan 24 526 0.7× 394 0.8× 544 1.6× 129 0.4× 260 1.1× 103 1.8k
Rajvir Singh Qatar 24 866 1.2× 517 1.0× 703 2.0× 335 1.2× 245 1.1× 106 2.2k
Wen‐Ter Lai Taiwan 26 1.6k 2.2× 690 1.4× 319 0.9× 302 1.0× 292 1.3× 229 2.6k
Ronen Durst Israel 21 494 0.7× 592 1.2× 316 0.9× 361 1.2× 202 0.9× 87 1.8k
Pedro Moreno Spain 18 446 0.6× 373 0.8× 398 1.1× 494 1.7× 115 0.5× 77 1.7k

Countries citing papers authored by Matthias Frick

Since Specialization
Citations

This map shows the geographic impact of Matthias Frick's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Matthias Frick with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Matthias Frick more than expected).

Fields of papers citing papers by Matthias Frick

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Matthias Frick. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Matthias Frick. The network helps show where Matthias Frick may publish in the future.

Co-authorship network of co-authors of Matthias Frick

This figure shows the co-authorship network connecting the top 25 collaborators of Matthias Frick. A scholar is included among the top collaborators of Matthias Frick based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Matthias Frick. Matthias Frick is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zweiker, David, Iréne Lang, Sabine Perl, et al.. (2024). Renal sympathetic denervation 2024 in Austria: recommendations from the Austrian Society of Hypertension. Wiener klinische Wochenschrift. 136(S14). 559–569.
2.
Saely, Christoph H., Andreas Leiherer, Matthias Frick, et al.. (2024). Antibody levels versus vaccination status in the outcome of older adults with COVID-19. JCI Insight. 9(20).
3.
Saely, Christoph H., et al.. (2023). Association between Lipid Levels, Anti-SARS-CoV-2 Spike Antibodies and COVID-19 Mortality: A Prospective Cohort Study. Journal of Clinical Medicine. 12(15). 5068–5068. 2 indexed citations
4.
Verheyen, Nicolas, Kathrin Danninger, Franz Duca, et al.. (2022). Diagnostic Accuracy of Bone Scintigraphy for the Histopathological Diagnosis of Cardiac Transthyretin Amyloidosis—A Retrospective Austrian Multicenter Study. Biomedicines. 10(12). 3052–3052. 2 indexed citations
5.
Reinstadler, Sebastian J., Martin Reindl, Ivan Lechner, et al.. (2020). Effect of the COVID-19 Pandemic on Treatment Delays in Patients with ST-Segment Elevation Myocardial Infarction. Journal of Clinical Medicine. 9(7). 2183–2183. 44 indexed citations
6.
Suessenbacher, Alois, Jakob Dörler, Sabrina Neururer, et al.. (2014). Sex differences in independent factors associated with coronary artery disease. Wiener klinische Wochenschrift. 126(21-22). 718–726. 6 indexed citations
7.
Widimský, Petr, J. Wouter Jukema, Bernhard Meier, et al.. (2012). Evolving strategies in the management of acute coronary syndromes with oral antiplatelet agents. Cor et Vasa. 54(1-2). e32–e38. 4 indexed citations
8.
Poelzl, Gerhard, et al.. (2012). Concomitant renal and hepatic dysfunctions in chronic heart failure: Clinical implications and prognostic significance. European Journal of Internal Medicine. 24(2). 177–182. 28 indexed citations
9.
Alber, Hannes, Kurt Huber, Otmar Pachinger, & Matthias Frick. (2011). Prasugrel vs. Ticagrelor in acute coronary syndromes: Which one to choose?. Wiener klinische Wochenschrift. 123(15-16). 468–476. 4 indexed citations
10.
Pölzl, Gerhard & Matthias Frick. (2009). Transplantvaskulopathie - Pathophysiologie, Diagnose und Therapie. Journal für Kardiologie (Krause & Pachernegg GmbH). 16(3). 80–84.
11.
Poelzl, Gerhard, et al.. (2009). Prevalence and Prognostic Significance of Elevated γ-Glutamyltransferase in Chronic Heart Failure. Circulation Heart Failure. 2(4). 294–302. 70 indexed citations
12.
Frick, Matthias & Franz Weidinger. (2007). Endothelial Function: A Surrogate Endpoint in Cardiovascular Studies?. Current Pharmaceutical Design. 13(17). 1741–1750. 31 indexed citations
13.
Poelzl, Gerhard, Matthias Frick, Hannes Alber, et al.. (2005). Chronic Heart Failure is Associated with Vascular Remodeling of the Brachial Artery. European Journal of Heart Failure. 7(1). 43–48. 26 indexed citations
14.
Zwick, Ralf Harun, Gert Klug, Matthias Frick, et al.. (2005). CORRELATION OF CARDIOVASCULAR RISK SCORES WITH MYOCARDIAL HIGH-ENERGY PHOSPHATE METABOLISM. CHEST Journal. 128(4). 285S–285S.
15.
Dichtl, Wolfgang, Wolfgang Vogel, Karin M. Dunst, et al.. (2005). Cardiac hepatopathy before and after heart transplantation. Transplant International. 18(6). 697–702. 68 indexed citations
16.
Zwick, Ralf Harun, Franz Xaver Roithinger, Matthias Frick, et al.. (2004). Positive Inotropic Therapy Decreases Vascular Endothelial Growth Factor in Patients with Low Output Syndrome. CHEST Journal. 126(4). 773S–773S. 1 indexed citations
17.
Frick, Matthias, et al.. (2002). Flußvermittelte Vasodilatation (FMD) der Arteria brachialis: Methodik und klinischer Stellenwert. Journal für Kardiologie (Krause & Pachernegg GmbH). 9(10). 439–444. 4 indexed citations
18.
Weidinger, Franz, Matthias Frick, Hannes Alber, et al.. (2002). Association of wall thickness of the brachial artery measured with high-resolution ultrasound with risk factors and coronary artery disease. The American Journal of Cardiology. 89(9). 1025–1029. 38 indexed citations
19.
20.
Frick, Matthias, et al.. (1974). [The pregnostic value of isotope cisternograms for shunt operations for communication hydrocephalus (author's transl)].. PubMed. 121(5). 634–43. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Takehiro Matsumoto Breakdown of academic impact, for papers by Yi‐Da Tang Breakdown of academic impact, for papers by Masayuki Takamura Breakdown of academic impact, for papers by Steven J.R. Meex Breakdown of academic impact, for papers by Devaki Nair Breakdown of academic impact, for papers by Yuichi Nakamura Breakdown of academic impact, for papers by Rajvir Singh Breakdown of academic impact, for papers by Wen‐Ter Lai Breakdown of academic impact, for papers by Ronen Durst Breakdown of academic impact, for papers by Pedro Moreno
Rankless by CCL
2026